Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Oxidative stress is linked to mild patchy alopecia areata.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The Seoul International Dermatology Symposium was a successful event that highlighted new dermatology treatments and fostered international relations.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Targeting Vδ1+T-cells may help treat alopecia areata.

Infliximab may cause hair loss in Crohn's disease patients.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.